D. Walker

发表

The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein

Vicente E. Torres, Dawn S. Milliner, Peter C. Harris, 2002, Nature Genetics.

Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity

D. Walker, J. Reid, M. Ames, 1996, Cancer Chemotherapy and Pharmacology.

DNA methylation profiling: comparison of genome-wide sequencing methods and the Infinium Human Methylation 450 Bead Chip.

J. Cunningham, S. Baheti, Zhifu Sun, 2015, Epigenomics.

CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene.

D. O'Kane, J. Black, D. Walker, 2012, Pharmacogenomics.

Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065

D. Walker, J. Reid, M. Ames, 2004, Cancer Chemotherapy and Pharmacology.

Aminonicotinamide Sensitizes Human Tumor Cell Lines to Cisplatin 1

S. Kaufmann, G. Poirier, G. Shah, 2005 .

The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.

V. Torres, P. Harris, S. Rossetti, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Upper endoscopy for occult bleeding in renal failure.

A. Keshavarzian, D. Walker, H. Hodgson, 1987, Journal of clinical gastroenterology.

Studies of Humoral Immunity to Preprohypocretin in Human Leukocyte Antigen DQB1*0602–Positive Narcoleptic Subjects with Cataplexy

L. Krahn, J. Black, M. Silber, 2005, Biological Psychiatry.

HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF lgG reactive to rat hypothalamic protein extract.

L. Krahn, J. Black, M. Silber, 2005, Sleep.

Study of in Vivo pyrazoloacridine metabolism by capillary electrophoresis using isotachophoresis preconcentration in non‐aqueous separation buffer

L. Benson, A. Tomlinson, D. Walker, 1993 .

The Metabolism of Pyrazoloacridine (NSC 366140) by Cytochromes P450 and Flavin Monooxygenase in Human Liver Microsomes

L. Benson, A. Tomlinson, P. LoRusso, 2004, Clinical Cancer Research.

Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients.

T. Lesnick, W. Kremers, D. O'Kane, 2012, Leukemia research.

6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin.

S. Kaufmann, G. Poirier, G. Shah, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent.

S. Kaufmann, D. Walker, P. Svingen, 1999, Biochemical pharmacology.

A complete mutation screen of the ADPKD genes by DHPLC.

V. Torres, P. Harris, S. Rossetti, 2002, Kidney international.

Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

J. Miller, K. Bae, P. Thompson, 2007, Journal of the American Society of Nephrology : JASN.

Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.

K. Bae, S. Özen, A. Chapman, 2008, Kidney international.

The occurrence of selected physiologic responses to cholecystectomy in normal and overweight adults

D. Walker, 1990 .

Analysis of hypocretin (orexin) antibodies in patients with narcolepsy.

V. Pankratz, L. Krahn, J. Black, 2005, Sleep.

Frequency of Undetected CYP2D6 Hybrid Genes in Clinical Samples: Impact on Phenotype Prediction

D. O'Kane, J. Black, D. Walker, 2012, Drug Metabolism and Disposition.

Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states.

M. Frye, O. Abulseoud, J. Biernacka, 2013, The international journal of neuropsychopharmacology.

CYP2D6: novel genomic structures and alleles

D. Mrazek, D. O'Kane, J. Black, 2009, Pharmacogenetics and genomics.

Adenosinergic Regulation of Striatal Clock Gene Expression and Ethanol Intake During Constant Light

Christina L. Ruby, O. Abulseoud, D. Walker, 2014, Neuropsychopharmacology.

Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients

M. Stegall, D. Mrazek, J. Black, 2011, Depression and anxiety.

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.

J. Sloan, R. Goldberg, A. Adjei, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.

Brian A Palmer, M. Frye, S. McElroy, 2015, The Journal of clinical psychiatry.

Sex-Specific Regulation of Depression, Anxiety-Like Behaviors and Alcohol Drinking in Mice Lacking ENT1.

Christina L. Ruby, D. Walker, D. Choi, 2011, Journal of addiction research & therapy.

Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain

J. Black, D. Walker, W. Hooten, 2013, BMC Medical Genetics.

Testing a diathesis-stress model: potential genetic risk factors for development of distress in context of acute leukemia diagnosis and transplant.

D. Mrazek, J. Black, D. Walker, 2012, Psychosomatics.

Relationship of genetic variation in the serotonin transporter gene (SLC6A4) and congenital and acquired cardiovascular diseases.

J. Black, D. Walker, S. Ehlers, 2015, Genetic testing and molecular biomarkers.

Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.

S. Özen, A. Chapman, P. Lundquist, 2008, Kidney international.

Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients

M. Stegall, D. Mrazek, J. Black, 2011, Depression and anxiety.